| PERIOD ENDING | 31-Dec-07 | 31-Mar-07 | 30-Jun-06 | 31-Mar-06 | | Total Revenue | 108,613 | 93,110 | 115,405 | 100,814 | | Cost of Revenue | 30,569 | 29,018 | 32,798 | 33,347 | | | Gross Profit | 78,044 | 64,092 | 82,607 | 67,467 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,575 | 34,061 | 46,614 | 39,248 | | Non Recurring | (24,973) | (97) | 333,553 |
-
| | Others | 14,259 | 15,020 | 17,549 | 19,370 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 53,183 | 15,108 | (315,109) | 8,849 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 331 | (304) | (7,011) | 2,616 | | Earnings Before Interest And Taxes | 53,514 | 14,701 | (318,168) | 11,704 | | Interest Expense | 14,983 | 17,963 | 17,607 | 16,748 | | Income Before Tax | 38,531 | (3,262) | (335,775) | (5,044) | | Income Tax Expense | 15,057 | (1,276) | (91,418) | (725) | | Minority Interest |
-
| 182 | 3,952 | 239 | | | | Net Income From Continuing Ops | 23,474 | (1,986) | (244,357) | (4,319) | | | Non-recurring Events | | Discontinued Operations | 4,229 | 22,718 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,703 | 20,732 | (244,357) | (4,319) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $27,703 | $20,732 | ($244,357) | ($4,319) |
|
0.14% Nasdaq 
0.16%
Income Statement
